73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
Vorträge Dienstag, 31.05.2022
Maligne Gliome I/Malignant gliomas I
Meeting Abstract
(V220)
[Full Text]
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma
Mijderwijk HJ, Nieboer D, Incekara F, Berger K, Steyerberg E, van den Bent MJ, Reifenberger G, Hänggi D, Smits M, Senft CA, Rapp M, Sabel M, Voss M, Forster MT, Kamp MA[Full Text]
Meeting Abstract
(V221)
[Full Text]
The intra-tumoral heterogeneity in glioblastoma – a limitation for prognostic value of epigenetic markers?
Sippl C, Saenz A, Teping F, Trenkpohl V, Ketter R, Kim YJ, Oertel J, Urbschat S[Full Text]
Meeting Abstract
(V222)
[Full Text]
The clinical frailty scale as predictor of overall survival after resection of high-grade glioma
Klingenschmid J, Krigers A, Pinggera D, Kerschbaumer J, Freyschlag CF, Thomé C[Full Text]
Meeting Abstract
(V223)
[Full Text]
Genomic characterisation of IDH-Wildtype Glioblastoma in different age groups
Richter S, Stasik S, Schackert G, Thiede C, Krex D, Juratli T[Full Text]
Meeting Abstract
(V225)
[Full Text]
A role for resective surgery in the treatment of multicentric/multifocal glioblastoma
Dimov D, Simon M, Grote A, Berger B, Coras R, Brainman D[Full Text]
Meeting Abstract
(V226)
[Full Text]
Diagnostic discrepancy between MRI-based non-GBM like tumours and molecular GBM-confirmation based on the 2021-WHO-classification of CNS tumours
Bytyqi F, Lotfinia M, Koch A, Sergejew F, Spüntrup E, Walter J, Walter-Diessars M[Full Text]
Meeting Abstract
(V227)
[Full Text]
Impact of antiepileptic drug treatment on 5-aminolevulinic acid fluorescence expression in IDH-1 wild-type glioblastoma
Wach J, Güresir Á, Hamed M, Vatter H, Herrlinger U, Becker A, Güresir E[Full Text]
Meeting Abstract
(V228)
[Full Text]
First results of the TIGER study – treatment decision and quality of life of glioblastoma patients during TTFields therapy in routine clinical care
Bähr O, Tabatabai G, Fietkau R, Goldbrunner R, Glas M[Full Text]